Page last updated: 2024-10-24

carvedilol and Hypercholesterolemia

carvedilol has been researched along with Hypercholesterolemia in 6 studies

Hypercholesterolemia: A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.

Research Excerpts

ExcerptRelevanceReference
" The present experiment evaluated the effects of carvedilol, a new beta adrenoreceptor blocker with potent free radical-scavenging activity, on myocardial ischemia and reperfusion injury in a hypercholesterolemic rabbit model."7.69Carvedilol, a new beta adrenoreceptor blocker and free radical scavenger, attenuates myocardial ischemia-reperfusion injury in hypercholesterolemic rabbits. ( Barone, FC; Christopher, TA; Feuerstein, GZ; Lopez, BL; Ma, XL; Ruffolo, RR; Yue, TL, 1996)
" The present experiment evaluated the effects of carvedilol, a new beta adrenoreceptor blocker with potent free radical-scavenging activity, on myocardial ischemia and reperfusion injury in a hypercholesterolemic rabbit model."3.69Carvedilol, a new beta adrenoreceptor blocker and free radical scavenger, attenuates myocardial ischemia-reperfusion injury in hypercholesterolemic rabbits. ( Barone, FC; Christopher, TA; Feuerstein, GZ; Lopez, BL; Ma, XL; Ruffolo, RR; Yue, TL, 1996)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oh, PC1
Kang, WC1
Moon, J1
Park, YM1
Kim, S1
Kim, MG1
Lee, K1
Ahn, T1
Shin, EK1
Baulmann, J1
Schunkert, H1
Rakov, AL1
Nikitin, AV1
Riabov, AIu1
Ma, XL1
Yue, TL1
Lopez, BL1
Barone, FC1
Christopher, TA1
Ruffolo, RR2
Feuerstein, GZ2
Fisher, M1
Nunnart, J1
Donetti, E1
Soma, MR1
Barberi, L1
Paoletti, R1
Fumagalli, R1
Roma, P1
Catapano, AL1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparison of Carvedilol and Atenolol on Anti-anginal and Metabolic Effects in Patients With Stable Angina Pectoris[NCT02547597]Phase 499 participants (Actual)Interventional2011-04-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for carvedilol and Hypercholesterolemia

ArticleYear
Anti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2016, Volume: 16, Issue:3

    Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Angina, Stable; Atenolol; Carbazoles; Cardiotonic Agen

2016
[Evaluation of the effectivenes of treatment of patients with renal arterial hypertension with carvedilol].
    Klinicheskaia meditsina, 2006, Volume: 84, Issue:6

    Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Carvedilol; Female; Fosinopril; Humans;

2006

Other Studies

4 other studies available for carvedilol and Hypercholesterolemia

ArticleYear
[Elevated augmentation index].
    Deutsche medizinische Wochenschrift (1946), 2012, Volume: 137, Issue:6

    Topics: Anticholesteremic Agents; Antihypertensive Agents; Azetidines; Bisoprolol; Blood Pressure; Carbazole

2012
Carvedilol, a new beta adrenoreceptor blocker and free radical scavenger, attenuates myocardial ischemia-reperfusion injury in hypercholesterolemic rabbits.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 277, Issue:1

    Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Carbazoles; Carvedilol; Endothelium, Vascular;

1996
Carvedilol inhibits aortic lipid deposition in the hypercholesterolemic rat.
    Pharmacology, 1997, Volume: 54, Issue:1

    Topics: Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Arteriosclerosis; Calcium Channel Blockers; C

1997
Dual effects of the antioxidant agents probucol and carvedilol on proliferative and fatty lesions in hypercholesterolemic rabbits.
    Atherosclerosis, 1998, Volume: 141, Issue:1

    Topics: Adrenergic beta-Antagonists; Animals; Anticholesteremic Agents; Antihypertensive Agents; Antioxidant

1998